7th Annual Pharma Project & Portfolio Management 2024

24 November 2023

After the success of the previous six editions, Eminence Business Media is delighted to announce the 7th Annual Pharma Project & Portfolio Management 2024. It is an eagerly anticipated event for the pharma industry’s most demanding i.e., portfolio teams and results-driven teams i.e., project teams. This event serves as a comprehensive platform for project and […]

By Akshay Parmar

24 November 2023

After the success of the previous six editions, Eminence Business Media is delighted to announce the 7th Annual Pharma Project & Portfolio Management 2024. It is an eagerly anticipated event for the pharma industry’s most demanding i.e., portfolio teams and results-driven teams i.e., project teams. This event serves as a comprehensive platform for project and portfolio professionals to navigate their day-to-day challenges and envision the future of the pharma sector.

This year’s program has been meticulously crafted to encourage thought-provoking discussions, addressing current challenges such as skill gaps, competitive knowledge deficiencies, intellectual property trends, and the evolving landscape of project management.

The event will feature expert-led creative sessions, real-world case studies, interactive Q&A sessions, practical soft skill development, and networking opportunities. High-ranking executives and pharma experts from project and portfolio management will provide insights, strategies, and solutions to help individuals achieve their organizational objectives.

Participating in the 7th Annual Pharma Project & Portfolio Management 2024 offers an opportunity to engage in stimulating and specialized discussions on niche topics while gaining unique perspectives on problem-solving.

Reasons to Attend:

  • Gain insight into intellectual property rights and portfolio challenges within the pharma industry.
  •  Address technical questions and enhance soft skills through creatively structured sessions.
  • Explore project management concepts and tackle methodological dilemmas.
  • Learn from experts through panel discussions at the end of each day.
  • Participate in dedicated Q&A sessions to discuss and resolve queries after each session.
  • Access six months of continuous learning support.

Who Should Attend:

Presidents, Managing Directors, CXOs, Sr. VPs, VPs, Sr. GMs, GMs, as well as Managers and Pharma Professionals from various teams, including –

  • Portfolio Management Teams
  • Project Management Teams
  • IPR Teams
  • Finance Teams
  • Supply Chain Management Teams
  •  Academia Students

Comentarios

No Comments